Publikationen (283) Publikationen von MIGUEL ÁNGEL RUBIO HERRERA

2024

  1. A Simplified Screening Model to Predict the Risk of Gestational Diabetes Mellitus in Caucasian and Latin American Pregnant Women

    Genes, Vol. 15, Núm. 4

  2. Does the Prevalence of Obesity in the Different Regions of Spain Influence the Attitudes, Perception, and Barriers to Its Treatment?

    Obesity Facts, Vol. 17, Núm. 3, pp. 264-273

  3. Early Mediterranean-Based Nutritional Intervention Reduces the Rate of Gestational Diabetes Mellitus in Overweight and Obese Pregnant Women: A Post-Hoc Analysis of the San Carlos Gestational Prevention Study

    Dietetics and nutrition

  4. Early Mediterranean-Based Nutritional Intervention Reduces the Rate of Gestational Diabetes in Overweight and Obese Pregnant Women: A Post-Hoc Analysis of the San Carlos Gestational Prevention Study

    Nutrients, Vol. 16, Núm. 14

  5. Isolated hypoaldosteronism is a cause of hypovolemic but not euvolemic hyponatremia

    Endocrine Connections, Vol. 13, Núm. 3

  6. Milk Ladder for Reintroduction of Cow’s Milk in Infants With IgE-Mediated Cow’s Milk Allergy: Version Adapted to the Spanish Population

    Journal of Investigational Allergology and Clinical Immunology

  7. Minerals and trace elements in pregnancy in women with previous bariatric surgery consequences on maternal and foetal health

    Journal of Trace Elements in Medicine and Biology, Vol. 85

  8. Outcomes of Bariatric Surgery in Patients with Schizophrenia

    Nutrients, Vol. 16, Núm. 15

  9. Revisional surgery for malnutrition after SADI-S: prevalence, indications, techniques and outcomes

    Updates in Surgery, Vol. 76, Núm. 5, pp. 1879-1885

  10. Two-Stage Conversion of Roux-en-Y Gastric Bypass to SADI-S

    Obesity Surgery, Vol. 34, Núm. 8, pp. 3084-3086

2023

  1. An Early Mediterranean-Based Nutritional Intervention during Pregnancy Reduces Metabolic Syndrome and Glucose Dysregulation Rates at 3 Years Postpartum

    Nutrients, Vol. 15, Núm. 14

  2. Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus

    Journal of Clinical Medicine, Vol. 12, Núm. 1

  3. Clinical and economic impact of COVID-19 on people with obesity in a Spanish cohort during the first pandemic peak

    Frontiers in Endocrinology, Vol. 14

  4. Combined Effect of Genetic Variants on Long-Term Weight Response after Bariatric Surgery

    Journal of Clinical Medicine, Vol. 12, Núm. 13

  5. Imbalance in Bone Morphogenic Proteins 2 and 7 Is Associated with Renal and Cardiovascular Damage in Chronic Kidney Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

  6. Impact of Treatment with GLP1 Receptor Agonists, Liraglutide 3.0 mg and Semaglutide 1.0 mg, While on a Waiting List for Bariatric Surgery

    Biomedicines, Vol. 11, Núm. 10

  7. Micronutrients in Pregnancy after Bariatric Surgery: A Narrative Review

    Journal of Clinical Medicine, Vol. 12, Núm. 16

  8. Mixed Meal Tolerance Test Versus Continuous Glucose Monitoring for an Effective Diagnosis of Persistent Post-Bariatric Hypoglycemia

    Journal of Clinical Medicine, Vol. 12, Núm. 13

  9. Modifiable Risk Factors and Trends in Changes in Glucose Regulation during the First Three Years Postdelivery: The St Carlos Gestational Diabetes Mellitus Prevention Cohort

    Nutrients, Vol. 15, Núm. 23

  10. New IFSO/ASMBS Indications for Metabolic and Bariatric Surgery? Yes, After Failure of Best Nonsurgical Therapy

    Obesity Surgery